Anne Osbourn

Osbourn, Anne

doi:10.1111/nph.13616

Cited by 3 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[1] In microorganisms, the biosynthetic genes for the production of as econdary metabolite are usually grouped togetheri n as ingle cluster. [2] Because similar or identical compounds have been isolated from different speciesw ith highly homologous gene clusters, it has been proposed that horizontal gene transfer of the biosynthetic gene clusters can accelerate theird istribution ande volution. [3] Although the biosynthesis of secondary metabolites, in mostr eported cases, is completed within as ingle gene cluster,r ecent biosynthetic studies have revealed numerous examples in which the biosynthesis of secondary metabolites requires genes outside the cluster.…”

mentioning

confidence: 99%

Structural Diversification of Lyngbyatoxin A by Host‐Dependent Heterologous Expression of the tleABC Biosynthetic Gene Cluster

et al. 2016

View full text Add to dashboard Cite

Natural products have enormous structural diversity, yet little is known about how such diversity is achieved in nature. Here we report the structural diversification of a cyanotoxin—lyngbyatoxin A—and its biosynthetic intermediates by heterologous expression of the Streptomyces‐derived tleABC biosynthetic gene cluster in three different Streptomyces hosts: S. lividans, S. albus, and S. avermitilis. Notably, the isolated lyngbyatoxin derivatives, including four new natural products, were biosynthesized by crosstalk between the heterologous tleABC gene cluster and the endogenous host enzymes. The simple strategy described here has expanded the structural diversity of lyngbyatoxin A and its biosynthetic intermediates, and provides opportunities for investigation of the currently underestimated hidden biosynthetic crosstalk.

show abstract

mentioning

confidence: 99%

Structural Diversification of Lyngbyatoxin A by Host‐Dependent Heterologous Expression of the tleABC Biosynthetic Gene Cluster

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Danach konzentrierte man sich bei Cambridge Antibody Te chnology (Medimmune/AstraZeneca) darauf,s ehr große Bibliotheken (> 10 11 Klone) zu erzeugen, die immer wieder auf Antikçrper gegen verschiedene pharmazeutische Ziele durchsucht werden kçnnen. Zum Beispiel wurde die gleiche Phagenantikçrper-Bibliothek verwendet, um Antikçrper gegen die in Tablle 3aufgelisteten Ziele zu entwickeln, [57] und Tabelle 4z eigt diejenigen humanen therapeutischen Antikçrper, die bereits von der US Food and Drug Administration zugelassen sind.…”

Section: Nobelaufsätze Therapeutische Antikçrper Von Phagenunclassified

Medikamentenentwicklung mithilfe der Evolution (Nobel‐Vortrag)

Winter

2019

Angewandte Chemie

View full text Add to dashboard Cite

show abstract

“…A medicinal plant is a plant that “contains substances that can be used for therapeutic purposes or which are precursors for the synthesis of useful drugs.” 1 Medicinal plants contain different classes of potentially bioactive compounds, including, but not limited to peptides, alkaloids, phenylpropanoids, polyketides, and terpenoids. 2 Such compounds have alleged and in certain cases documented anticancer, anti-inflammatory, antioxidant, antibacterial, antipyretic, vasodilatory, stimulant, and/or more properties that have been historically used in traditional medicine. 1,3 Evidence suggests that medicinal plants have been used for at least 60,000 years in places including what would be modern-day Iraq.…”

Section: Introductionmentioning

confidence: 99%

Investigating and Identifying Traditional Medicinal Plant Antioxidants– New Frontiers in Treating Age-related Maladies Associated with Oxidative Stress

Gammell,

Gangji,

Leibovitz

et al. 2023

Preprint

View full text Add to dashboard Cite

Oxidative stress is regarded as an imbalance between pro-oxidant and antioxidant species that can result in cellular inflammation associated with illnesses including cancers and cognitive decline. This study investigated medicinal plant extracts for the presence of natural bioactive compounds to explore their antioxidant properties and potential therapeutic relevance in conditions related to oxidative stress. Extracts were created using water as a solvent and compared in triplicate to the positive control quercetin (1 mg/mL) in a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay; all extracts were serially diluted from 10 mg/mL creating 8 distinct concentrations. Absorbance readings were compared before and after DPPH administration. At the highest concentration, all extracts demonstrated absorbance change factors <10% relative to the DPPH negative control. This result clearly demonstrated antioxidant activity, as lesser relative absorbance changes indicated greater neutralization of violet DPPH into lighter diphenylpicryl hydrazine via free radical scavenging. Most notably, at lowest concentration,Averrhoa carambolaandPsidium guajavarepresented the least relative absorbance changes at 14.17% and 10.39%, rivaling quercetin’s antioxidant activity– a statistically significant result (p < 0.05). LC-MS/MS analysis of these most potent extracts identified quercetin and kaempferol inPsidium guajavaand vitexin-2’’-O-rhamnoside, isovitexin, saponarin, and an additional flavonoid glycoside inAverrhoa carambola. Such compounds may offer potential pharmacological effects, for example, vitexin-2’’-O-rhamnoside and isovitexin have demonstrated anticancer, antidiabetic, neuroprotective, and cardioprotective properties in part through oxidative stress reduction. Future research should corroborate compound effects in human cell culture models, as prior studies are often limited to non-human tissues.INTRODUCTIONA medicinal plant is a plant that “contains substances that can be used for therapeutic purposes or which are precursors for the synthesis of useful drugs.”1Medicinal plants contain different classes of potentially bioactive compounds, including, but not limited to peptides, alkaloids, phenylpropanoids, polyketides, and terpenoids.2Such compounds have alleged and in certain cases documented anticancer, anti-inflammatory, antioxidant, antibacterial, antipyretic, vasodilatory, stimulant, and/or more properties that have been historically used in traditional medicine.1,3Evidence suggests that medicinal plants have been used for at least 60,000 years in places including what would be modern-day Iraq.4Medicinal plants are still used all around the world today; Dr. Tedros Adhanom Ghebreyesus of the WHO says “For many millions of people around the world, traditional medicine is the first port of call to treat many diseases.”5In addition, the prevalence of medicinal plants is evident in developed countries too, with the medicinal plant trade between India and China accounting for two to five billion dollars annually.1However, many of these traditional treatments receive significant scrutiny from modern medicine and society’s decreasing reliance on plant-derived drugs. While such scrutiny proves accurate in many cases, several traditional medicinal plants have been shown to offer bioactive compounds that are used as a standard medical practice. This includes morphine, “a natural alkaloid that is derived from resin extracts from the seeds of the opium poppy,”3which is utilized in clinical settings for its profound analgesic effects,3and quinine, an antimalarial drug derived fromCinchona officinalisbark.6The current research project presented herein will serve to test traditional medicinal plant compounds to determine if their claims of relevance can be substantiated and to explore their potential effects on biological organisms, specifically regarding their antioxidant properties and ability to eliminate free radicals. Free radicals are unstable molecular species with unpaired electrons,7and can contribute to oxidative stress in organisms. Oxidative stress “is considered as an imbalance between pro- and antioxidant species, which results in molecular and cellular damage.”8Examples of known antioxidants include the polyphenol quercetin, which is often used as a positive control for its relative strength in reducing free radicals.9Demonstrated efficacy of these medicinal plants could provide potential preventative therapies for age-related illnesses and other maladies associated with oxidative stress, including cancers and cognitive decline.8,9RESEARCH QUESTIONS AND PURPOSEDo the traditional medicinal plants under investigation contain bioactive compounds with antioxidant properties capable of neutralizing free radicals in a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay?How does the efficacy of the plant extracts compare to the positive control, quercetin, and the associated samples in terms of antioxidant activity as measured by the DPPH assay?Do the extract compounds identified via LC-MS/MS analysis offer potential therapeutic relevance in modern medicine?With our research, we aimed to identify bioactive compounds within medicinal plants, determine if such medicinal plants and their bioactive compounds have applications in modern medical treatments, and ensure medicinal plants are being used safely and accurately under the support of sound scientific evidence.

show abstract

Anne Osbourn

Cited by 3 publications

References 5 publications

Structural Diversification of Lyngbyatoxin A by Host‐Dependent Heterologous Expression of the tleABC Biosynthetic Gene Cluster

Structural Diversification of Lyngbyatoxin A by Host‐Dependent Heterologous Expression of the tleABC Biosynthetic Gene Cluster

Medikamentenentwicklung mithilfe der Evolution (Nobel‐Vortrag)

Investigating and Identifying Traditional Medicinal Plant Antioxidants– New Frontiers in Treating Age-related Maladies Associated with Oxidative Stress

Contact Info

Product

Resources

About